![John R. Garrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
John R.
Garrett is currently the Co-Chief Executive Officer at Glycosyn LLC and the Executive Director at Glycosyn Health Initiatives, Inc. He previously worked as a Director at Advanced Proteome Therapeutics Corp.
Aktive Positionen von John R. Garrett
Unternehmen | Position | Beginn |
---|---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Vorstandsvorsitzender | - |
Glycosyn Health Initiatives, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von John R. Garrett
Unternehmen | Position | Ende |
---|---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Health Technology |
Glycosyn Health Initiatives, Inc. |